Xiao-Yan Zhang (Xiaoyan Zhang)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 6

Top Topics

Epithelial Mesenchymal Transition

Locally Advanced

Top Venues

Molecular imaging

Journal of nanobiotechnology

Journal of cellular physiology

This page only lists publications with an associated author ORCID identifier.

Publications

Tao Pu, Yawei Liu, Yuetian Pei, Jing Peng, Zehua Wang, Ming Du, Qiyu Liu, Fangfang Zhong, Mingxing Zhang, Fuyou Li, Cong-Jian Xu, Xiao-Yan Zhang
NIR-II Fluorescence Imaging for the Detection and Resection of Cancerous Foci and Lymph Nodes in Early-Stage Orthotopic and Advanced-Stage Metastatic Ovarian Cancer Models. ACS applied materials & interfaces (2023)
Jing Peng, Qiyu Liu, Tao Pu, Mingxing Zhang, Meng Zhang, Ming Du, Guiling Li, Xiao-Yan Zhang, Cong-Jian Xu
Targeted Imaging of Endometriosis and Image-Guided Resection of Lesions Using Gonadotropin-Releasing Hormone Analogue-Modified Indocyanine Green. Molecular imaging 2023 (2023)
Meng Zhang, Qiyu Liu, Mingxing Zhang, Cong Cao, Xiaoxia Liu, Mengyu Zhang, Guiling Li, Congjian Xu, Xiao-Yan Zhang
Enhanced antitumor effects of follicle-stimulating hormone receptor-mediated hexokinase-2 depletion on ovarian cancer mediated by a shift in glucose metabolism. Journal of nanobiotechnology 18 (1) (2020)
Ming-Xing Zhang, Shan-Shan Hong, Qing-Qing Cai, Meng Zhang, Jun Chen, Xiao-Yan Zhang, Cong-Jian Xu
Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo. Drug delivery 25 (1) (2018)
Mengyu Zhang, Mingxing Zhang, Jing Wang, Qingqing Cai, Ran Zhao, Yi Yu, Haiyan Tai, Xiao-Yan Zhang, Cong-Jian Xu
Retro-inverso follicle-stimulating hormone peptide-mediated polyethylenimine complexes for targeted ovarian cancer gene therapy. Drug delivery 25 (1) (2018)
Meng Zhang, Qing Cong, Xiao-Yan Zhang, Ming-Xing Zhang, Ying-Ying Lu, Cong-Jian Xu
Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation. Journal of cellular physiology 234 (5) (2018)